RxDoctor Payments Data

Marshall Merrell

Optometrist · Rexburg, IDNPI 1992894232

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,110 of the $6,377 with a category attached, or 64.5%. 10 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 39.0% of the total. Reporting peaked in 2024 at $2,353 and has fallen 89.0% since, to $258 in 2025. Among optometrist clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,377in general payments, 2019–2025

Across 128 payments — averaging $49.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb Americas Inc.$2K
  • Alcon$2K
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$586
  • Johnson & Johnson Vision Care, Inc.$519
  • Coopervision Inc.$200
  • ABB Con-cise Optical Group LLC$122
  • plus $265 from 4 others

What the payments were for

  • Travel & lodging$2,26736%
  • Food & beverage$4,11064%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,377 in reported general payments places this provider in the 95th percentile of 304 optometrist providers in Idaho.

See all optometrist providers in Idaho

Medicare billing

Part B allowed, 2024
$71,379
Medicare patients
384
Services billed
846

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ZirganGanciclovir18$8,158
AlrexLoteprednol Etabonate14$7,155
Loteprednol Etabonate13$2,602
Timolol Maleate24$453
Latanoprost19$216

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Bausch & Lomb, A Division Of Bausch Health US, LLCAlrex, Loteprednol Etabonate$586$9,75727 claims
Bausch & Lomb Americas Inc.Zirgan$2,484$8,15818 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 304 optometrist providers in Idaho.

Other optometrist in Rexburg

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →